CCBG vs NBIX · P/E 12, rev $204.4M vs P/E 45, rev $1.77B
Capital City Bank Group (CCBG) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Capital City Bank Group (CCBG) is a banks - regional company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CCBG revenue for 2025-12-31 was $204.4M. Net income was $61.6M. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. CCBG currently screens at market cap $701.6M and trailing P/E 12.2.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
CCBG currently screens at market cap $701.6M and trailing P/E 12.2. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the CCBG and NBIX stock pages for the full models.
Not investment advice.